Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Duminuco

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Blood and Lymphatic Cancer : Targets and Therapy|December 26, 2023
Polycythemia Vera: Barriers to and Strategies for Optimal ManagementAndrea Duminuco, Patrick Harrington, Claire Harrison, et al.
Current Hematologic Malignancy Reports|July 3, 2023
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative DiseasesAndrea Duminuco, Elena Torre, Giuseppe A Palumbo, et al.
Expert Opinion on Pharmacotherapy|June 21, 2023
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitorsAndrea Duminuco, Calogero Vetro, Cesarina Giallongo, et al.
Cancer Reports (Hoboken, N.J.)|August 9, 2023
AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinibAndrea Duminuco, Adrian Mosquera-Orgueira, Antonella Nardo, et al.
Cancers|January 11, 2024
ACVR1: A Novel Therapeutic Target to Treat Anemia in MyelofibrosisAndrea Duminuco, Helen T Chifotides, Sebastiano Giallongo, et al.
Annals of Hematology|July 1, 2026
A systematic review of 47 published cases of extramedullary hematopoiesis in myelofibrosis: clinical patterns, treatment responses, and prognostic implicationsAndrea Duminuco, Veronica Vecchio, Giulio Lavenia, et al.
Current Hematologic Malignancy Reports|May 3, 2025
Emerging Therapeutic Approaches for Anemia in MyelofibrosisHelen T Chifotides, Andrea Duminuco, Elena Torre, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 23, 2022
Acquired hemophilia A following COVID-19 vaccination - The importance of prompt diagnosis: A case reportAndrea Duminuco, Marianna Calagna, Uros Markovic, et al.
Journal of Clinical Medicine|February 15, 2022
Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on PhysiopathologyGiuseppe Milone, Claudia Bellofiore, Salvatore Leotta, et al.
Journal of Clinical Medicine|December 23, 2022
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life SettingAndrea Duminuco, Antonella Nardo, Bruno Garibaldi, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Blood and Lymphatic Cancer : Targets and Therapy|December 26, 2023
Polycythemia Vera: Barriers to and Strategies for Optimal ManagementAndrea Duminuco, Patrick Harrington, Claire Harrison, et al.
Current Hematologic Malignancy Reports|July 3, 2023
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative DiseasesAndrea Duminuco, Elena Torre, Giuseppe A Palumbo, et al.
Expert Opinion on Pharmacotherapy|June 21, 2023
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitorsAndrea Duminuco, Calogero Vetro, Cesarina Giallongo, et al.
Cancer Reports (Hoboken, N.J.)|August 9, 2023
AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinibAndrea Duminuco, Adrian Mosquera-Orgueira, Antonella Nardo, et al.
Cancers|January 11, 2024
ACVR1: A Novel Therapeutic Target to Treat Anemia in MyelofibrosisAndrea Duminuco, Helen T Chifotides, Sebastiano Giallongo, et al.
Annals of Hematology|July 1, 2026
A systematic review of 47 published cases of extramedullary hematopoiesis in myelofibrosis: clinical patterns, treatment responses, and prognostic implicationsAndrea Duminuco, Veronica Vecchio, Giulio Lavenia, et al.
Current Hematologic Malignancy Reports|May 3, 2025
Emerging Therapeutic Approaches for Anemia in MyelofibrosisHelen T Chifotides, Andrea Duminuco, Elena Torre, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 23, 2022
Acquired hemophilia A following COVID-19 vaccination - The importance of prompt diagnosis: A case reportAndrea Duminuco, Marianna Calagna, Uros Markovic, et al.
Journal of Clinical Medicine|February 15, 2022
Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on PhysiopathologyGiuseppe Milone, Claudia Bellofiore, Salvatore Leotta, et al.
Journal of Clinical Medicine|December 23, 2022
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life SettingAndrea Duminuco, Antonella Nardo, Bruno Garibaldi, et al.
Pageof 8